Constitutive expression of interleukin-lα precursor promotes human vascular smooth muscle cell proliferation

被引:30
|
作者
Beasley, D
Cooper, AL
机构
[1] Tufts Univ, Sch Med, New England Med Ctr Hosp, Dept Med,Div Nephrol, Boston, MA 02111 USA
[2] Tufts Univ, Sch Med, New England Med Ctr Hosp, Tupper Res Inst, Boston, MA 02111 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 1999年 / 276卷 / 03期
关键词
atherosclerosis; growth factors; interleukin-l receptor antagonist;
D O I
10.1152/ajpheart.1999.276.3.H901
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vascular smooth muscle cell (VSMC) proliferation plays a critical role in the failure of vascular surgeries and contributes to the development of atherosclerotic lesions. Evidence that interleukin-1 (IL-1) is a mitogen for cultured VSMC has implicated its release by activated macrophages in the development of atherosclerosis. VSMC also produce IL-1, including the precursor form of IL-1 alpha. However, it is not known whether IL-1 alpha precursor is processed to mature IL-1 alpha or released from VSMC, nor is it known whether either precursor or mature IL-1 alpha functions as an autocrine growth factor. The goals of the present study were to establish whether proliferation is enhanced in human VSMC transfectants producing IL-1 alpha constitutively at levels comparable to those produced after activation, and to determine which domains of IL-1 alpha are important for its activity. Human VSMC were stably transfected with expression vectors directing constitutive expression of either full-length IL-1 alpha precursor [IL-1 alpha-(1-271)], its NH2-terminal domain [IL-1 alpha-(1-112)], or mature IL-1 alpha [IL-1 alpha-(113-271)]. Both IL-1 alpha-(1-271) and IL-1 alpha-(113-271) stable transfectants produced moderate levels of IL-1 alpha (0.2-1.0 ng/10(6) cells) and released low levels of IL-1 alpha into the supernatant (<20 pg/ml). VSMC stably transfected with either IL-1 alpha-(1-271) or IL-1 alpha-(113-271) expression plasmids proliferated rapidly compared with nontransfected or vector-transfected VSMC and displayed a distinct morphology characterized by elongated, spindle-shaped cells. Stable transfection with IL-1 alpha-(1-271) was somewhat more effective than transfection with Il-1 alpha-(113-271). Interestingly, VSMC transfected with IL-1 alpha-(113-271) expression plasmids also expressed IL-1 alpha-(1-271) mRNA, suggesting that IL-1 alpha-(113-271) activates an IL-1-induced IL-1 autocrine loop. In contrast, neither proliferation rates nor morphology was affected by stable transfection with IL-1 alpha-(1-112) expression plasmids. Exogenous IL-1 receptor antagonist partially reversed the enhanced DNA synthesis in VSMC transfected with either IL-1 alpha-(1-271) or IL-1 alpha-(113-271) expression plasmids, suggesting that the pro-proliferative effect of VSMC-derived IL-1 alpha is at least partially mediated by signaling via the type I IL-1 receptor. These results demonstrate that IL-1 alpha precursor is an autocrine growth factor for human VSMC and further indicate that amino acids 113-271 play a crucial role in its actions.
引用
收藏
页码:H901 / H912
页数:12
相关论文
共 50 条
  • [31] Synergistic effect of urotensin II with serotonin on vascular smooth muscle cell proliferation
    Watanabe, T
    Pakala, R
    Katagiri, T
    Benedict, CR
    JOURNAL OF HYPERTENSION, 2001, 19 (12) : 2191 - 2196
  • [32] Regulation of vascular smooth muscle cell proliferation role of NF-κΒ revisited
    Mehrhof, FB
    Schmidt-Ullrich, R
    Dietz, R
    Scheidereit, C
    CIRCULATION RESEARCH, 2005, 96 (09) : 958 - 964
  • [33] CD98 regulates vascular smooth muscle cell proliferation in atherosclerosis
    Baumer, Yvonne
    McCurdy, Sara
    Alcala, Martin
    Mehta, Nehal
    Lee, Bog-Hieu
    Ginsberg, Mark H.
    Boisvert, William A.
    ATHEROSCLEROSIS, 2017, 256 : 105 - 114
  • [34] Promotion of cultured vascular smooth muscle cell proliferation by low levels of cadmium
    Fujiwara, Y
    Watanabe, S
    Kaji, T
    TOXICOLOGY LETTERS, 1998, 94 (03) : 175 - 180
  • [35] Serotonin potentiates angiotensin II - induced vascular smooth muscle cell proliferation
    Watanabe, T
    Pakala, R
    Katagiri, T
    Benedict, CR
    ATHEROSCLEROSIS, 2001, 159 (02) : 269 - 279
  • [36] WISP1 overexpression promotes proliferation and migration of human vascular smooth muscle cells via AKT signaling pathway
    Lu, Shun
    Liu, Hao
    Lu, Lihe
    Wan, Heng
    Lin, Zhiqi
    Qian, Kai
    Yao, Xingxing
    Chen, Qing
    Liu, Wenjun
    Yan, Jianyun
    Liu, Zhengjun
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2016, 788 : 90 - 97
  • [37] CTRP3/cartducin is induced by transforming growth factor-β1 and promotes vascular smooth muscle cell proliferation
    Maeda, Takashi
    Wakisaka, Satoshi
    CELL BIOLOGY INTERNATIONAL, 2010, 34 (03) : 261 - 266
  • [38] Endogenous cannabinoid receptor CB1 activation promotes vascular smooth-muscle cell proliferation and neointima formation
    Molica, Filippo
    Burger, Fabienne
    Thomas, Aurelien
    Staub, Christian
    Tailleux, Anne
    Staels, Bart
    Pelli, Graziano
    Zimmer, Andreas
    Cravatt, Benjamin
    Matter, Christian M.
    Pacher, Pal
    Steffens, Sabine
    JOURNAL OF LIPID RESEARCH, 2013, 54 (05) : 1360 - 1368
  • [39] Human sLZIP promotes atherosclerosis via MMP-9 transcription and vascular smooth muscle cell migration
    Kim, Jeonghan
    Ko, Jesang
    FASEB JOURNAL, 2014, 28 (11) : 5010 - 5021
  • [40] The CCL5/CCR5 Axis Promotes Vascular Smooth Muscle Cell Proliferation and Atherogenic Phenotype Switching
    Lin, Chin-Sheng
    Hsieh, Po-Shiuan
    Hwang, Ling-Ling
    Lee, Yen-Hsien
    Tsai, Shih-Hung
    Tu, Yun-Chin
    Hung, Yao-Wen
    Liu, Cheng-Che
    Chuang, Yi-Ping
    Liao, Min-Tser
    Chien, Shu
    Tsai, Min-Chien
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 47 (02) : 707 - 720